Allotment of 11.5 lakh shares on warrant conversion

Warrants ConvertedFund Raising View source PDF Explain this filing

AAREYDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹108.75

prior close

₹108.56

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-1.8% vs market

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

-0.2

15m

-0.8

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.1-0.2-1.8

Next day

-4.9-3.0-2.0

-3.3-2.7-0.5

-3.1-1.9-1.2

-5.7-1.7-4.0

-1.7-1.0-0.6

+3.9-2.0+5.9

15d

+1.6pendingpending

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved allotment of 11,50,000 equity shares on conversion of warrants at Rs. 63.80 per share (premium of Rs. 53.80). Company received Rs. 5.50 crore being 75 percent of issue price from both promoter and non-promoter allottees. After this, paid-up equity capital rises to Rs. 31.87 crore from Rs. 30.72 crore. About 14.80 lakh warrants are still pending conversion before May 2026. This is a revised outcome correcting the previous annexure table.

Likely market impact

Around 3.7 percent share dilution from warrant conversion. 14.8 lakh more warrants pending, which may dilute further if converted.